Startups
Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company with multiple technology platforms targeting select cardiovascular indications and autoimmune diseases.
Overview
Location
United States, New Jersey, Bernards Township
Employees
11-50
Phone
+1 908-842-0100
Founded date
2006
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 5, 2021 | Caladrius Biosciences : Reports First Quarter 2021 Financial Results and Provides Business Update | Conference call begins today at 4:30 p.m. Eastern Time BASKING RIDGE, N.J. (May 6, 2021) - Caladrius Biosciences, Inc. (Nasdaq: CLBS) ('Caladrius' or the 'Company'), a clinical-stage biopharmaceutical company dedicated to the development of... |
| May 12, 2021 | CALADRIUS BIOSCIENCES, INC. Caladrius Biosciences Receives $1.4 Million of Non-Dilutive Capital Through New Jersey Technology Business Tax Certificate Transfer Program | BASKING RIDGE, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to rever... |
| May 6, 2021 | CALADRIUS BIOSCIENCES, INC. Caladrius Biosciences : Reports First Quarter 2021 Financial Results and Provides Business Update | Conference call begins today at 4:30 p.m. Eastern Time BASKING RIDGE, N.J. (May 6, 2021) - Caladrius Biosciences, Inc. (Nasdaq: CLBS) ('Caladrius' or the 'Company'), a clinical-stage biopharmaceutical company dedicated to the development of... |
| Feb 1, 2021 | 3 Things to Know About Coronary Microvascular Dysfunction (CMD): A Heart Condition You’ve Probably Never Heard Of | (BPT) - In a time when health concerns are top of mind, it’s critical to be aware of underlying issues that may be impacting your overall health and quality of life. According to the U.S. Centers for Disease Control and Prevention (CDC), he... |
| Feb 1, 2021 | 3 Things to Know About Coronary Microvascular Dysfunction (CMD): A Heart Condition You’ve Probably Never Heard Of | (BPT) - In a time when health concerns are top of mind, it’s critical to be aware of underlying issues that may be impacting your overall health and quality of life. According to the U.S. Centers for Disease Control and Prevention (CDC), he... |
| Mar 6, 2018 | After bagging Shire’s cell therapy castoff, Caladrius stock climbs | After Shire’s $32 billion buyout of Baxalta back in 2016, the company has been purging its unwanted assets to biotechs with barren pipelines. Now, one of those programs is landing in familiar hands. Caladrius Biosciences $... |
Reviews 0
FAQ about Caladrius Biosciences, Inc.
When was Caladrius Biosciences, Inc. founded?
Caladrius Biosciences, Inc. was founded in 2006.
What has the press written about Caladrius Biosciences, Inc.?
Parsers VC has collected 7 articles mentioning Caladrius Biosciences, Inc., among them “Caladrius Biosciences : Reports First Quarter 2021 Financial Results and Provides Business Update” (Jun 5, 2021) and “CALADRIUS BIOSCIENCES, INC. Caladrius Biosciences Receives $1.4 Million of Non-Dilutive Capital Through New Jersey Technology Business Tax Certificate Transf...” (May 12, 2021).
Is Caladrius Biosciences, Inc. still active?
Yes, Caladrius Biosciences, Inc. is active; its latest activity on Parsers VC dates from Mar 1, 2022.